… . “The deal shows that large pharma players are still willing to … acquisition of Metsera, which develops drugs for obesity and metabolic diseases, on Monday. The … three future payments based on drug-development results. Both companies are based …

Ascletis Pharma announced its muscle-preserving weight loss drug candidate ASC47, in … . Evaluations of safety Tolerability Pharmacokinetics Assessment of weight losses of … combination study designs for multiple metabolic diseases such as obesity and metabolic …

Current treatment strategies for endocrine and metabolic diseases are … failure and inherited metabolic diseases. We follow … how different treatments affect brain development and cognition … endocrinology and inherited metabolic diseases at Karolinska Institutet …

… liver diseases and metabolic disorders, expand the patient … stages of clinical development, major pharmaceutical companies are … and Drug Administration (FDA) had granted Orphan Drug Designation … cancer treatments, visit @ Advanced Liver Cancer Drugs Table …

… approach to treating schizophrenia has … (motor control) issues, metabolic disorders and cardiovascular complications, while … drug developers recognize the commercial opportunity for new medications … drugs and digital therapies demonstrating that new treatment …

… prescribed for the treatment of vaginal infections … diseases, gastrointestinal health, metabolic disorders, cardiovascular disease, osteoporosis, … and OTC medications, to retail pharmacies and … including accelerated product development, advanced R…

… treatments for weight management and other chronic conditions. Notably, drugs … their effectiveness in treating obesity and related … , an oral medication aimed at metabolic diseases. READ: Eli … boundaries of pharmaceutical research and development, investing in …

… starting points for drug development. Unlike traditional … breakthrough and orphan drugs, rising venture capital … integration of translational pharmacology and biomarker strategies … Infectious Diseases, Cardiovascular, Metabolic Disorders – Moderate growth with …

… this understanding by treating drug delivery not … Unlike conventional drugs with fixed pharmacological properties, adaptive … targeted treatment for inflammatory bowel disease or metabolic disorders … the development of evidence based regulatory frameworks (FDA, …

… the discovery and development of the next … not limited to drug delivery, pharmacology, organic synthesis, … targeting lysosomal storage disorders, metabolic diseases, and solid tumors. … modifying treatments for untreatable or difficult-to-treat disorders …